These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 11956193)

  • 1. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage.
    Malfait AM; Liu RQ; Ijiri K; Komiya S; Tortorella MD
    J Biol Chem; 2002 Jun; 277(25):22201-8. PubMed ID: 11956193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human aggrecanase 2 (ADAM-TS5): substrate specificity studies and comparison with aggrecanase 1 (ADAM-TS4).
    Tortorella MD; Liu RQ; Burn T; Newton RC; Arner E
    Matrix Biol; 2002 Oct; 21(6):499-511. PubMed ID: 12392761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
    Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone enhances aggrecanase-2/ADAM-TS5 expression and proteoglycan degradation in growth plate cartilage.
    Makihira S; Yan W; Murakami H; Furukawa M; Kawai T; Nikawa H; Yoshida E; Hamada T; Okada Y; Kato Y
    Endocrinology; 2003 Jun; 144(6):2480-8. PubMed ID: 12746310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
    Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
    Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.
    Stanton H; Rogerson FM; East CJ; Golub SB; Lawlor KE; Meeker CT; Little CB; Last K; Farmer PJ; Campbell IK; Fourie AM; Fosang AJ
    Nature; 2005 Mar; 434(7033):648-52. PubMed ID: 15800625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
    Roughley PJ; Barnett J; Zuo F; Mort JS
    Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of aggrecanase and MMP in cartilage degradation].
    Ishiguro N; Kojima T
    Clin Calcium; 2004 Jul; 14(7):38-44. PubMed ID: 15577074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cleavage of biglycan by aggrecanases.
    Melching LI; Fisher WD; Lee ER; Mort JS; Roughley PJ
    Osteoarthritis Cartilage; 2006 Nov; 14(11):1147-54. PubMed ID: 16806997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes.
    Tortorella MD; Arner EC; Hills R; Easton A; Korte-Sarfaty J; Fok K; Wittwer AJ; Liu RQ; Malfait AM
    J Biol Chem; 2004 Apr; 279(17):17554-61. PubMed ID: 14715656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and activity of ADAMTS-5 in synovium.
    Vankemmelbeke MN; Holen I; Wilson AG; Ilic MZ; Handley CJ; Kelner GS; Clark M; Liu C; Maki RA; Burnett D; Buttle DJ
    Eur J Biochem; 2001 Mar; 268(5):1259-68. PubMed ID: 11231277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
    Sawaji Y; Hynes J; Vincent T; Saklatvala J
    Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.
    Struglics A; Larsson S; Pratta MA; Kumar S; Lark MW; Lohmander LS
    Osteoarthritis Cartilage; 2006 Feb; 14(2):101-13. PubMed ID: 16188468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggrecanases and cartilage matrix degradation.
    Nagase H; Kashiwagi M
    Arthritis Res Ther; 2003; 5(2):94-103. PubMed ID: 12718749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis.
    Lohmander LS; Neame PJ; Sandy JD
    Arthritis Rheum; 1993 Sep; 36(9):1214-22. PubMed ID: 8216415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.
    Tortorella M; Pratta M; Liu RQ; Abbaszade I; Ross H; Burn T; Arner E
    J Biol Chem; 2000 Aug; 275(33):25791-7. PubMed ID: 10827174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
    Huang K; Wu LD
    J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.